Clinical trial

The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine)…

NCT00425451 · Dexcel Pharma Technologies Ltd., Industry · Completed

Key facts

NCT number NCT00425451
Title The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis
Official title The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis
Lead sponsor Dexcel Pharma Technologies Ltd., Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Periodontitis
Intervention type Drug
Interventions PerioChip Plus (Flurbiprofen +Chlorhexidine ), Flurbiprofen Chip, PerioChip (Chlorhexidine ) and Placebo Chip
Enrollment 80
Start date Aug 1, 2008
Primary completion Jan 1, 2009
Completion Mar 1, 2009
First posted Jan 23, 2007
Last update posted Jun 14, 2011
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies